Progressive resistance training not superior for hip osteoarthritis
Apr 08, 2024
Progressive resistance training was not superior to neuromuscular exercise for improving functional performance, hip pain and quality of life.
Prevalence of arthritis in US adults 18.9 percent in 2022
Mar 01, 2024
Women were more likely to have arthritis than men; the prevalence increased with older age.
NIA start-up grant winner includes AI-chatbot for pain management
By
Aaron Dorman
Feb 29, 2024
An NIA grant program is funding a new start-up that uses conversational AI to address seniors’ pain concerns.
Clinicians support telehealth for managing seniors’ chronic conditions, study shows
By
Aaron Dorman
Feb 26, 2024
A majority of clinicians believe that telehealth can play a crucial role in improving practices for chronic conditions, new research shows.
Therapeutic intervention feasible for preventing rheumatoid arthritis in patients at risk
Feb 23, 2024
Fewer patients progressed to rheumatoid arthritis versus those receiving placebo.
Acupuncture linked to lower incidence of ischemic stroke in RA
Feb 16, 2024
The cumulative incidence of ischemic stroke was lower among patients receiving acupuncture versus no acupuncture.
GERD can induce occurrence of rheumatoid arthritis, but not vice versa
Jan 31, 2024
A Bidirectional Mendelian randomization analysis showed a 69% increased risk for RA occurrence for GERD patients.
494 million people had other musculoskeletal disorders globally in 2020
Dec 22, 2023
The category of “other musculoskeletal disorders” comprises a residual musculoskeletal category for conditions other than osteoarthritis, rheumatoid arthritis, gout, low back pain and neck...
Senior communities offered opportunity for remote patient monitoring, services in ‘Clinic Days’ launch
By
Aaron Dorman
Dec 12, 2023
The launch of a clinic program by Hospital in Your Home focuses on establishing remote patient monitoring for older adults with chronic diseases.
Four JAK inhibitors have comparable efficacy, safety for RA
Dec 01, 2023
Baseline CRP, Clinical Disease Activity Index and glucocorticoid dose predict resistance to CDAI-low disease activity achievement.